Repurposing the antihyperglycemic drug into an anti-glaucoma agent:  Metformin, the widely prescribed drug in the treatment of TIIDM, increases Nmnat1 expression, increases NAD+ levels, improves neuronal dysfunction, and protects against glaucoma,  via down regulation of its target gene, 29/March/2019, 10.53 am